HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eric J Arts Selected Research

Vesicular Stomatitis

5/2023Optimal Expression, Function, and Immunogenicity of an HIV-1 Vaccine Derived from the Approved Ebola Vaccine, rVSV-ZEBOV.
4/2023Monovalent and trivalent VSV-based COVID-19 vaccines elicit neutralizing antibodies and CD8+ T cells against SARS-CoV-2 variants.
11/2022Correction: A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2.
12/2021A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2.
9/2017Development of an HIV vaccine using a vesicular stomatitis virus vector expressing designer HIV-1 envelope glycoproteins to enhance humoral responses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eric J Arts Research Topics

Disease

16Infections
03/2024 - 10/2002
5Vesicular Stomatitis
05/2023 - 09/2017
4Acquired Immunodeficiency Syndrome (AIDS)
08/2019 - 02/2007
3COVID-19
01/2024 - 12/2021
3HIV Infections (HIV Infection)
10/2023 - 07/2004
3Viremia
01/2018 - 03/2009
2Disease Progression
10/2023 - 10/2012
1Persistent Infection
03/2024
1Virus Diseases (Viral Diseases)
12/2022
1Neoplasms (Cancer)
09/2017

Drug/Important Bio-Agent (IBA)

7VaccinesIBA
05/2023 - 10/2002
3EpitopesIBA
04/2009 - 11/2007
2RNA (Ribonucleic Acid)IBA
01/2024 - 03/2009
2Proteins (Proteins, Gene)FDA Link
10/2023 - 04/2023
2Neutralizing AntibodiesIBA
11/2022 - 12/2021
2Antiviral Agents (Antivirals)IBA
04/2012 - 03/2009
2N(alpha)- (n- nonanoyl)- desSer(1)- (thioproline(2),cyclohexylglycine(3))- RANTESIBA
05/2009 - 07/2004
2Anti-Infective Agents (Microbicides)IBA
05/2009 - 07/2004
1WastewaterIBA
01/2024
1DeoxycytidineIBA
10/2023
1AerosolsIBA
12/2022
1COVID-19 VaccinesIBA
12/2021
1SolutionsIBA
12/2021
1MitogensIBA
09/2020
1AntigensIBA
09/2020
1AIDS VaccinesIBA
09/2017
1Glycoproteins (Glycoprotein)IBA
09/2017
1nef Gene Products (nef Gene Product)IBA
11/2016
1env Gene ProductsIBA
05/2015
1Protease Inhibitors (Protease Inhibitor)IBA
10/2012
1HLA-B57 antigenIBA
05/2011
1Small Interfering RNA (siRNA)IBA
01/2011
1Anti-Retroviral Agents (Antiretroviral Agents)IBA
05/2010
1Peptides (Polypeptides)IBA
11/2007
1Reverse Transcriptase InhibitorsIBA
03/2007
1NucleosidesIBA
03/2007
1NucleotidesIBA
03/2007
1Chemokine CCL5IBA
07/2004

Therapy/Procedure

7Therapeutics
03/2024 - 02/2007
2Highly Active Antiretroviral Therapy (HAART)
03/2007 - 02/2007
1Hormonal Contraception
10/2023
1Art Therapy
03/2009